ArticleComputational and structural biotechnology journal2025
PanARGMiner (Pan-Genomic Antimicrobial Resistance Gene Miner): An advanced feature selection framework for extracting key resistance genes from pan-genomic datasets.
Article in Computational and structural biotechnology journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Beyond Random Splits: Assessing the Generalization of Graph and Vector Models for WT-Structure-Only Drug Resistance Prediction under Protein-Disjoint Evaluation.Computational and structural biotechnology journal · 2026Article
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Identifying antimicrobial resistance (AMR)-related biomarkers from large-scale genomic datasets is often akin to finding a needle in a haystack. With pan-genomic data containing more than 100,000 gene sequences, isolating features that truly drive resistance remains a major challenge in computational biology. Here we present PanARGMiner, a machine learning-based feature selection framework designed to robustly extract highly relevant and informative biomarkers from high-dimensional biological data. PanARGMiner uses an ensemble-based feature selection strategy to select highly informative and compact feature subsets. It then utilizes repeated iterations to ensure the stability and reliability of the proposed framework, enabling PanARGMiner to generate significantly reduced features with comparable prediction performance compared to those obtained with other feature selection algorithms. Applying PanARGMiner to bacterial pan-genomic antimicrobial resistance datasets successfully extracted as few as one to ten candidate AMR biomarkers from datasets with more than 100,000 genes for five common pathogens. Although many of the extracted candidate AMR biomarkers are well-known resistance genes, proteins not known to be associated with AMR mechanisms, including functionally uncharacterized hypothetical proteins, were also extracted. This indicates the potential of PanARGMiner in revealing both established and novel mechanisms of antibiotic resistance, thus providing actionable insights for biomarker discovery, functional genomics, and precision medicine based on complex data. Its ability to uncover both known and uncharacterized resistance-related features offers new opportunities for research and clinical applications in combating AMR.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.